Hereditary transthyretin amyloidosis presenting with prominent autonomic dysfunction.

AMYLOID AUTONOMIC CARDIOLOGY NEUROPATHY

Journal

Practical neurology
ISSN: 1474-7766
Titre abrégé: Pract Neurol
Pays: England
ID NLM: 101130961

Informations de publication

Date de publication:
04 Jun 2024
Historique:
accepted: 17 05 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 4 6 2024
Statut: aheadofprint

Résumé

A 56-year-old man reported 2 years of slowly progressive exertional fatigue, presyncope, paraesthesia, generalised weakness and nocturnal bowel frequency. He had an abnormal Valsalva ratio and significant postural hypotension. Serum N-terminal pro-B-type natriuretic peptide and troponin T were elevated. Transthoracic echocardiogram identified thickening of the biventricular walls, interatrial septum and atrioventricular valve leaflets. Global longitudinal strain was reduced with relative apical sparing, suspicious for cardiac amyloidosis. Technetium-99m and 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy supported a diagnosis of transthyretin amyloidosis (ATTR). However, urinary Bence Jones protein (kappa) was identified despite a normal kappa/lambda light chain ratio and no serum paraprotein. Bone marrow and buccal biopsy provided histological confirmation of amyloid. The bone marrow had no evidence of plasma cell dyscrasia but positive TTR immunohistochemistry. The patient had a T60A genetic mutation for hereditary ATTR. Overlapping cardiac and autonomic symptoms prompt an amyloid workup, which then must distinguish AL amyloid from ATTR pathology.

Identifiants

pubmed: 38834303
pii: pn-2023-004048
doi: 10.1136/pn-2023-004048
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JG has consulting income from Ionis, Alexion, Eidos, Intellia, Alnylam and Pfizer.

Auteurs

Mary McCullagh (M)

Neurology, Altnagelvin Area Hospital, Derry, UK maryt.mccullagh@westerntrust.hscni.net.

Sinead Hughes (S)

Cardiology, Altnagelvin Area Hospital, Derry, UK.

Adam Canning (A)

Cardiology, Altnagelvin Area Hospital, Derry, UK.

Seamus Napier (S)

Pathology, Royal Victoria Hospital, Belfast, UK.

Julian Gillmore (J)

Centre for Amyloid and Acute Phase Proteins Division of Medicine, Royal Free Hospital, London, UK.

Mark Owen McCarron (MO)

Neurology, Altnagelvin Area Hospital, Derry, UK.

Classifications MeSH